Home > > > > Report Detail

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2020-2025

Publisher Name :
Date: 21-Sep-2020
No. of pages: 133

According to this study, over the next five years the 23-Valent Pneumococcal Polysaccharide Vaccine market will register a 14.9%% CAGR in terms of revenue, the global market size will reach $ 3513.8 million by 2025, from $ 2013.3 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in 23-Valent Pneumococcal Polysaccharide Vaccine business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of 23-Valent Pneumococcal Polysaccharide Vaccine market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the 23-Valent Pneumococcal Polysaccharide Vaccine, covering the supply chain analysis, impact assessment to the 23-Valent Pneumococcal Polysaccharide Vaccine market size growth rate in several scenarios, and the measures to be undertaken by 23-Valent Pneumococcal Polysaccharide Vaccine companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

- Single Dose Vial

- Pre-filled Syringe

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

- For Children (2-10)

- For Person (10-64)

- For The Old (=65)

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- United States

- Canada

- Mexico

- Brazil

- APAC

- China

- Japan

- Korea

- Southeast Asia

- India

- Australia

- Europe

- Germany

- France

- UK

- Italy

- Russia

- Middle East & Africa

- Egypt

- South Africa

- Israel

- Turkey

- GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

- MSD

- Sanofipasteur

- CDIBP

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global 23-Valent Pneumococcal Polysaccharide Vaccine consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

- To understand the structure of 23-Valent Pneumococcal Polysaccharide Vaccine market by identifying its various subsegments.

- Focuses on the key global 23-Valent Pneumococcal Polysaccharide Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the 23-Valent Pneumococcal Polysaccharide Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of 23-Valent Pneumococcal Polysaccharide Vaccine submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2020-2025

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2015-2025
2.1.2 23-Valent Pneumococcal Polysaccharide Vaccine Consumption CAGR by Region
2.2 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Type
2.2.1 Single Dose Vial
2.2.2 Pre-filled Syringe
2.3 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Type
2.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Type (2015-2020)
2.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Type (2015-2020)
2.3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Type (2015-2020)
2.4 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Application
2.4.1 For Children (2-10)
2.4.2 For Person (10-64)
2.4.3 For The Old (=65)
2.5 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Application
2.5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Type (2015-2020)
2.5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Value and Market Share by Type (2015-2020)
2.5.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Type (2015-2020)

3 Global 23-Valent Pneumococcal Polysaccharide Vaccine by Company
3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company
3.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Company (2018-2020)
3.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2018-2020)
3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company
3.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Company (2018-2020)
3.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company (2018-2020)
3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Company
3.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 23-Valent Pneumococcal Polysaccharide Vaccine by Regions
4.1 23-Valent Pneumococcal Polysaccharide Vaccine by Regions
4.2 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth
4.3 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth
4.4 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth
4.5 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth

5 Americas
5.1 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Countries
5.1.1 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Countries (2015-2020)
5.1.2 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Value by Countries (2015-2020)
5.2 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Type
5.3 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Regions
6.1.1 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Regions (2015-2020)
6.1.2 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Value by Regions (2015-2020)
6.2 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Type
6.3 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine by Countries
7.1.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Countries (2015-2020)
7.1.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Value by Countries (2015-2020)
7.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Type
7.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine by Countries
8.1.1 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Value by Countries (2015-2020)
8.2 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Type
8.3 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 23-Valent Pneumococcal Polysaccharide Vaccine Distributors
10.3 23-Valent Pneumococcal Polysaccharide Vaccine Customer

11 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast
11.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2021-2025)
11.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Regions
11.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Regions (2021-2025)
11.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Type
11.8 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Application

12 Key Players Analysis
12.1 MSD
12.1.1 Company Information
12.1.2 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered
12.1.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 MSD Latest Developments
12.2 Sanofipasteur
12.2.1 Company Information
12.2.2 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered
12.2.3 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Sanofipasteur Latest Developments
12.3 CDIBP
12.3.1 Company Information
12.3.2 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered
12.3.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 CDIBP Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. 23-Valent Pneumococcal Polysaccharide Vaccine Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Single Dose Vial
Table 5. Major Players of Pre-filled Syringe
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Type (2015-2020)
Table 8. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2015-2020) ($ million)
Table 9. Global 23-Valent Pneumococcal Polysaccharide Vaccine Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Application (2015-2020)
Table 13. Global 23-Valent Pneumococcal Polysaccharide Vaccine Value by Application (2015-2020)
Table 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Value Market Share by Application (2015-2020)
Table 15. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Application (2015-2020)
Table 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Company (2017-2019) (K Dose)
Table 17. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2017-2019)
Table 18. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Company (2017-2019) ($ Millions)
Table 19. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company (2017-2019)
Table 20. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Company (2017-2019)
Table 21. Global 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
Table 23. 23-Valent Pneumococcal Polysaccharide Vaccine Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Regions 2015-2020 (K Dose)
Table 25. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Regions 2015-2020
Table 26. Global 23-Valent Pneumococcal Polysaccharide Vaccine Value by Regions 2015-2020 ($ Millions)
Table 27. Global 23-Valent Pneumococcal Polysaccharide Vaccine Value Market Share by Regions 2015-2020
Table 28. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Countries (2015-2020) (K Dose)
Table 29. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Countries (2015-2020)
Table 30. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Value by Countries (2015-2020) ($ Millions)
Table 31. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Value Market Share by Countries (2015-2020)
Table 32. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Type (2015-2020) (K Dose)
Table 33. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Type (2015-2020)
Table 34. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Application (2015-2020) (K Dose)
Table 35. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Application (2015-2020)
Table 36. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Countries (2015-2020) (K Dose)
Table 37. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Countries (2015-2020)
Table 38. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Value by Regions (2015-2020) ($ Millions)
Table 39. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Value Market Share by Regions (2015-2020)
Table 40. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Type (2015-2020) (K Dose)
Table 41. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Type (2015-2020)
Table 42. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Application (2015-2020) (K Dose)
Table 43. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Application (2015-2020)
Table 44. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Countries (2015-2020) (K Dose)
Table 45. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Countries (2015-2020)
Table 46. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Value by Countries (2015-2020) ($ Millions)
Table 47. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Value Market Share by Countries (2015-2020)
Table 48. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Type (2015-2020) (K Dose)
Table 49. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Type (2015-2020)
Table 50. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Application (2015-2020) (K Dose)
Table 51. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Countries (2015-2020) (K Dose)
Table 53. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Type (2015-2020) (K Dose)
Table 57. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Application (2015-2020) (K Dose)
Table 59. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Application (2015-2020)
Table 60. 23-Valent Pneumococcal Polysaccharide Vaccine Distributors List
Table 61. 23-Valent Pneumococcal Polysaccharide Vaccine Customer List
Table 62. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast by Countries (2021-2025) (K Dose)
Table 63. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Forecast by Regions
Table 64. Global 23-Valent Pneumococcal Polysaccharide Vaccine Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global 23-Valent Pneumococcal Polysaccharide Vaccine Value Market Share Forecast by Regions
Table 66. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast by Type (2021-2025) (K Dose)
Table 67. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global 23-Valent Pneumococcal Polysaccharide Vaccine Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global 23-Valent Pneumococcal Polysaccharide Vaccine Value Market Share Forecast by Type (2021-2025)
Table 70. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast by Application (2021-2025) (K Dose)
Table 71. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global 23-Valent Pneumococcal Polysaccharide Vaccine Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global 23-Valent Pneumococcal Polysaccharide Vaccine Value Market Share Forecast by Application (2021-2025)
Table 74. MSD Product Offered
Table 75. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 76. MSD Main Business
Table 77. MSD Latest Developments
Table 78. MSD Basic Information, Company Total Revenue (in $ million), 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Sanofipasteur Product Offered
Table 80. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 81. Sanofipasteur Main Business
Table 82. Sanofipasteur Latest Developments
Table 83. Sanofipasteur Basic Information, Company Total Revenue (in $ million), 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. CDIBP Product Offered
Table 85. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 86. CDIBP Main Business
Table 87. CDIBP Latest Developments
Table 88. CDIBP Basic Information, Company Total Revenue (in $ million), 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 2. 23-Valent Pneumococcal Polysaccharide Vaccine Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth Rate 2015-2025 (K Dose)
Figure 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Single Dose Vial
Figure 7. Product Picture of Pre-filled Syringe
Figure 8. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Type (2015-2020)
Figure 9. Global 23-Valent Pneumococcal Polysaccharide Vaccine Value Market Share by Type (2015-2020)
Figure 10. 23-Valent Pneumococcal Polysaccharide Vaccine Consumed in For Children (2-10)
Figure 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: For Children (2-10) (2015-2020) (K Dose)
Figure 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: For Children (2-10) (2015-2020) ($ Millions)
Figure 13. 23-Valent Pneumococcal Polysaccharide Vaccine Consumed in For Person (10-64)
Figure 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: For Person (10-64) (2015-2020) (K Dose)
Figure 15. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: For Person (10-64) (2015-2020) ($ Millions)
Figure 16. 23-Valent Pneumococcal Polysaccharide Vaccine Consumed in For The Old (=65)
Figure 17. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: For The Old (=65) (2015-2020) (K Dose)
Figure 18. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: For The Old (=65) (2015-2020) ($ Millions)
Figure 19. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Application (2015-2020)
Figure 20. Global 23-Valent Pneumococcal Polysaccharide Vaccine Value Market Share by Application (2015-2020)
Figure 21. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company in 2017
Figure 22. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company in 2019
Figure 23. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company in 2017
Figure 24. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company in 2019
Figure 25. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Company in 2019
Figure 26. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Regions 2015-2020
Figure 27. Global 23-Valent Pneumococcal Polysaccharide Vaccine Value Market Share by Regions 2015-2020
Figure 28. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2015-2020 (K Dose)
Figure 29. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Value 2015-2020 ($ Millions)
Figure 30. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2015-2020 (K Dose)
Figure 31. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Value 2015-2020 ($ Millions)
Figure 32. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2015-2020 (K Dose)
Figure 33. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Value 2015-2020 ($ Millions)
Figure 34. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2015-2020 (K Dose)
Figure 35. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Value 2015-2020 ($ Millions)
Figure 36. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Countries in 2019
Figure 37. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Value Market Share by Countries in 2019
Figure 38. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Type in 2019
Figure 39. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Application in 2019
Figure 40. United States 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2015-2020 (K Dose)
Figure 41. United States 23-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2015-2020 ($ Millions)
Figure 42. Canada 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2015-2020 (K Dose)
Figure 43. Canada 23-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2015-2020 ($ Millions)
Figure 44. Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2015-2020 (K Dose)
Figure 45. Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2015-2020 ($ Millions)
Figure 46. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Countries in 2019
Figure 47. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Value Market Share by Regions in 2019
Figure 48. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Type in 2019
Figure 49. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Application in 2019
Figure 50. China 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2015-2020 (K Dose)
Figure 51. China 23-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2015-2020 ($ Millions)
Figure 52. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2015-2020 (K Dose)
Figure 53. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2015-2020 ($ Millions)
Figure 54. Korea 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2015-2020 (K Dose)
Figure 55. Korea 23-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2015-2020 ($ Millions)
Figure 56. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2015-2020 (K Dose)
Figure 57. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2015-2020 ($ Millions)
Figure 58. India 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2015-2020 (K Dose)
Figure 59. India 23-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2015-2020 ($ Millions)
Figure 60. Australia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2015-2020 (K Dose)
Figure 61. Australia 23-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2015-2020 ($ Millions)
Figure 62. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Countries in 2019
Figure 63. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Value Market Share by Countries in 2019
Figure 64. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Type in 2019
Figure 65. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Application in 2019
Figure 66. Germany 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2015-2020 (K Dose)
Figure 67. Germany 23-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2015-2020 ($ Millions)
Figure 68. France 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2015-2020 (K Dose)
Figure 69. France 23-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2015-2020 ($ Millions)
Figure 70. UK 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2015-2020 (K Dose)
Figure 71. UK 23-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2015-2020 ($ Millions)
Figure 72. Italy 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2015-2020 (K Dose)
Figure 73. Italy 23-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2015-2020 ($ Millions)
Figure 74. Russia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2015-2020 (K Dose)
Figure 75. Russia 23-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2015-2020 ($ Millions)
Figure 76. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Countries in 2019
Figure 77. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Value Market Share by Countries in 2019
Figure 78. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Type in 2019
Figure 79. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Application in 2019
Figure 80. Egypt 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2015-2020 (K Dose)
Figure 81. Egypt 23-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2015-2020 ($ Millions)
Figure 82. South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2015-2020 (K Dose)
Figure 83. South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2015-2020 ($ Millions)
Figure 84. Israel 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2015-2020 (K Dose)
Figure 85. Israel 23-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2015-2020 ($ Millions)
Figure 86. Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2015-2020 (K Dose)
Figure 87. Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2015-2020 ($ Millions)
Figure 88. GCC Countries 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2015-2020 (K Dose)
Figure 89. GCC Countries 23-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2015-2020 ($ Millions)
Figure 90. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth Rate Forecast (2021-2025) (K Dose)
Figure 91. Global 23-Valent Pneumococcal Polysaccharide Vaccine Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 92. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Dose)
Figure 93. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 94. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Dose)
Figure 95. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 96. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Dose)
Figure 97. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 98. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Dose)
Figure 99. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 100. United States 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Dose)
Figure 101. United States 23-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 102. Canada 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Dose)
Figure 103. Canada 23-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 104. Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Dose)
Figure 105. Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 106. Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Dose)
Figure 107. Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 108. China 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Dose)
Figure 109. China 23-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 110. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Dose)
Figure 111. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 112. Korea 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Dose)
Figure 113. Korea 23-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 114. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Dose)
Figure 115. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 116. India 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Dose)
Figure 117. India 23-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 118. Australia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Dose)
Figure 119. Australia 23-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 120. Germany 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Dose)
Figure 121. Germany 23-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 122. France 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Dose)
Figure 123. France 23-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 124. UK 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Dose)
Figure 125. UK 23-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 126. Italy 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Dose)
Figure 127. Italy 23-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 128. Russia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Dose)
Figure 129. Russia 23-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 130. Spain 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Dose)
Figure 131. Spain 23-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 132. Egypt 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Dose)
Figure 133. Egypt 23-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 134. South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Dose)
Figure 135. South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 136. Israel 23-Valent Pneumococcal Polysaccharide Vacc
  • Global Encephalitis Vaccination Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 102
    According to our LPI (LP Information) latest study, the global Encephalitis Vaccination market size was valued at US$ 1263.1 million in 2023. With growing demand in downstream market, the Encephalitis Vaccination is forecast to a readjusted size of US$ 1875.5 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global Encephalitis Vaccination market. Encephalitis Vaccination are expected to show stable growth in the future m......
  • Global Avian Influenza Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 123
    Market Overview of Global Avian Influenza Vaccines market: According to our latest research, the global Avian Influenza Vaccines market looks promising in the next 5 years. As of 2022, the global Avian Influenza Vaccines market was estimated at USD 933.69 million, and it's anticipated to reach USD 1586.45 million in 2028, with a CAGR of 9.24% during the forecast years. Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. ......
  • Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period. The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent P......
  • Global Avian Influenza Vaccines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155
    According to our LPI (LP Information) latest study, the global Avian Influenza Vaccines market size was valued at US$ 928.4 million in 2023. With growing demand in downstream market, the Avian Influenza Vaccines is forecast to a readjusted size of US$ 1369 million by 2030 with a CAGR of 5.7% during review period. The research report highlights the growth potential of the global Avian Influenza Vaccines market. Avian Influenza Vaccines are expected to show stable growth in the future mark......
  • Global Encephalitis Vaccination Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 106
    Market Overview of Global Encephalitis Vaccination market: According to our latest research, the global Encephalitis Vaccination market looks promising in the next 5 years. As of 2022, the global Encephalitis Vaccination market was estimated at USD 52963.61 million, and it's anticipated to reach USD 65320.29 million in 2028, with a CAGR of 3.56% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis......
  • Global Influenza Vaccine Market Research Report 2023
    Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 96
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Vaccine market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Sanofi - CSL - GSK - Viatris - AstraZeneca - Hualan Bio - Changchun Institute of Biological - Sinovac - BCHT - Jiangsu G......
  • Global Japanese Encephalitis Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 117
    Market Overview of Global Japanese Encephalitis Vaccine market: According to our latest research, the global Japanese Encephalitis Vaccine market looks promising in the next 5 years. As of 2022, the global Japanese Encephalitis Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......
  • Global Influenza Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Influenza Vaccine market: According to our latest research, the global Influenza Vaccine market looks promising in the next 5 years. As of 2022, the global Influenza Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses... ......
  • 2023-2031 Report on Global Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel
    Published: 11-Dec-2023        Price: US 2500 Onwards        Pages: 107
    This report studies the Influenza Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Pediatric, Adults, etc.), by sales channel (Direct Channel, Distribution Channel), by player (CSL, GSK, Sanofi, Mylan, AstraZeneca, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Influenza Vaccine from......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs